(+)-Oxanthromicin
(+)-Oxanthromicin (Compound 1) mislocalizes the oncogenic mutant K-Ras from the plasma membrane of intact Madin-Darby canine kidney (MDCK) cells, and exhibits thereby antitumor efficacy.
For research use only. We do not sell to patients.
- CAS No.: 1616622-08-2
- Formula: C36H30O12
- Molecular Weight:654.62
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
CAS No. 1616622-08-2
-
Molecular Weight 654.62
-
Formula C36H30O12
-
SMILES
C[C@]1(C2=CC(O)=C(C(O)=O)C(C)=C2C(C3=C(O)C(C)=CC=C31)=O)OO[C@@]4(C5=CC(O)=C(C(O)=O)C(C)=C5C(C6=C(O)C(C)=CC=C64)=O)C
-
Structure Classification
-
Initial Source
Streptomyces sp.
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Patient-Derived Xenograft (PDX)
Patient-derived xenograft (PDX) models are generated by engrafting primary human tumor tissue directly into immunodeficient mice, allowing in vivo propagation of patient tumor biology without initial in vitro adaptation. These models are used to preserve key histopathological and molecular characteristics of the original tumor and enable assessment of tumor growth dynamics and therapeutic response in a living organism. The biological readout is tumor engraftment and subsequent growth in the murine host, which reflects the ability of human tumor cells to survive, vascularize, and expand in an immunocompromised microenvironment.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)